Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 6, 2021; 9(19): 5270-5279
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5270
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5270
Figure 1 Ulcerative lesion in graft before and after administration infliximab.
A: The location of the diseases in the graft; B and C: Stenosis with inflammation in the proximal anastomosis between the graft and the original intestine (B, indicated by a white diamond in A), and a longitudinal ulcerative lesion in the distal end of the graft (C, indicated by a black diamond in A); D and E: Mucosal healing was observed in the distal ulcerative lesion after the administration of two doses of infliximab. IFN: Infliximab.
- Citation: Fujimura T, Yamada Y, Umeyama T, Kudo Y, Kanamori H, Mori T, Shimizu T, Kato M, Kawaida M, Hosoe N, Hasegawa Y, Matsubara K, Shimojima N, Shinoda M, Obara H, Naganuma M, Kitagawa Y, Hoshino K, Kuroda T. Maintenance treatment with infliximab for ulcerative ileitis after intestinal transplantation: A case report. World J Clin Cases 2021; 9(19): 5270-5279
- URL: https://www.wjgnet.com/2307-8960/full/v9/i19/5270.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i19.5270